More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$16.50B
EPS
2.25
P/E ratio
73.7
Price to sales
5.91
Dividend yield
0.189%
Beta
1.080399
Previous close
$148.85
Today's open
$149.22
Day's range
$146.84 - $151.43
52 week range
$81.22 - $171.74
show more
CEO
Prahlad R. Singh
Employees
11000
Headquarters
Waltham, MA
Exchange
New York Stock Exchange
Shares outstanding
111638757
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Diamond Hill Mid Cap Strategy Q3 2026 Portfolio Review
The Strategy declined 3.83% (net of fees) and the Russell Midcap Index declined 3.00%. Key contributors include Illumina, Revvity and Waystar. Key detractors include Regal Rexnord, Rocket Companies and Red Rock Resorts.
Seeking Alpha • 6 minutes ago

Revvity, Inc. (RVTY) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Revvity, Inc. (RVTY) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

Revvity to Showcase Strategy for Powering Scientific Intelligence at 2026 Investor Day
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today will host its 2026 Investor Day, highlighting the Company's differentiated portfolio of Life Sciences and Diagnostics solutions, as well as its position at the intersection of biology, experimentation and data. Under the theme "Powering Scientific Intelligence," Prahlad Singh, president and chief executive officer, and members of Revvity's senior leadership team will outline the Company's strategic priorities, recent operational.
Business Wire • Nov 13, 2026

ELV or RVTY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 11, 2026

All You Need to Know About Revvity (RVTY) Rating Upgrade to Buy
Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research • Nov 6, 2026

Madison Mid Cap Fund Q3 2026 Portfolio Activity
The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvity, and Waters Corporation. The bottom five detractors for the quarter were MKS, Floor & Decor Holdings, Carlisle Companies, Moelis and Co., and Glacier Bancorp.
Seeking Alpha • Nov 6, 2026

Revvity Q3 Earnings Call Highlights
Revvity NYSE: RVTY reported third-quarter results that exceeded its expectations, supported by stronger demand in its Life Sciences segment, continued growth in Diagnostics and expanding interest in artificial intelligence-related research tools.
MarketBeat • Nov 4, 2026

Revvity Faced Off With 'Elevated Investor Expectations' — And Won
Medical research stock Revvity surged on the back of a strong third-quarter report and heightened 2026 view.
Investors Business Daily • Nov 3, 2026

Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript
Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 3, 2026

Revvity Announces Financial Results for the Third Quarter of 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 4, 2026. The Company reported GAAP earnings per share from continuing operations of $0.56, as compared to $0.41 in the same period a year ago. Revenue for the quarter was $729 million, as compared to $699 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $95 million, as compared to $82 million for the same per.
Business Wire • Nov 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Revvity Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.